Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Neuroscience ; 198: 221-31, 2011 Dec 15.
Article in English | MEDLINE | ID: mdl-21884755

ABSTRACT

Parkinson's disease (PD) is the second most common neurodegenerative disease in developed countries. The core motor symptoms are attributable to the degeneration of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNc). Why these neurons succumb in PD is not clear. One potential clue has come from the observation that the engagement of L-type Ca²âº channels during autonomous pacemaking elevates the sensitivity of SNc DA neurons to mitochondrial toxins used to create animal models of PD, suggesting that Ca²âº entry is a factor in their selective vulnerability. Recent work has shown that this Ca²âº entry also elevates mitochondrial oxidant stress and that this stress is exacerbated by deletion of DJ-1, a gene associated with an early onset, recessive form of PD. Epidemiological data also support a linkage between L-type Ca²âº channels and the risk of developing PD. This review examines the hypothesis that the primary factor driving neurodegenerative changes in PD is the metabolic stress created by Ca²âº entry, particularly in the face of genetic or environmental factors that compromise oxidative defenses or proteostatic competence.


Subject(s)
Calcium/metabolism , Dopaminergic Neurons/pathology , Mitochondria/metabolism , Oxidative Stress/physiology , Parkinson Disease/pathology , Substantia Nigra/pathology , Animals , Calcium Channels, L-Type/metabolism , Dopamine Agents/pharmacology , Dopamine Agents/therapeutic use , Dopaminergic Neurons/ultrastructure , Humans , Levodopa/pharmacology , Levodopa/therapeutic use , Mitochondria/drug effects , Oxidative Stress/drug effects , Parkinson Disease/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...